Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for IDH1/2 Mutation in Adult AML

Kao, HW; Kuo, MC; Huang, YJ; Chang, H; Hu, SF; Huang, CF; Hung, YS; Lin, TL; Ou, CW; Lien, MY; Wu, JH; Chen, CC; Shih, LY

Shih, LY (通讯作者),Chang Gung Mem Hosp Linkou, Dept Internal Med, Div Hematol Oncol, Taoyuan 333423, Taiwan.;Shih, LY (通讯作者),Chang Gung Univ, Coll Med, Taoyuan 333323, Taiwan.

CANCERS, 2022; 14 (24):

Abstract

Simple Summary Measurable residual disease (MRD) monitoring is crucial in managing AML to predict the risk of relapse. A better understanding of which......

Full Text Link